Mette Kirstine Agger

Stages: Early Stage Venture, Late Stage Venture
Focus: Biotechnology, Venture Capital, Health Care, Therapeutics, Pharmaceutical, Medical, Biopharma, Medical Device, Manufacturing, Life Science, Hospital, Early Stage Venture, Late Stage Venture
Location: Copenhagen, Hovedstaden, Denmark

Managing Partner · Lundbeckfonden Ventures

Mette Kirstine Agger, as Managing Partner of Lundbeckfonden Ventures, invests in early-to-mid-stage biotechnology, health tech, and pharmaceutical companies—particularly those in clinical development—with typical check sizes of €3–€10 million [5]. Her portfolio includes notable life science firms such as Notify Therapeutics, AFYX Therapeutics, NMD Pharma, Tiburio (developing treatments for rare t…